JCB, Volume 15, Number 3, 2009 Editorial Vol.15 No. 3 (2009) The impact of the global financial crisis on biotechnology development Yali Friedman Most US states and many countries have long been dedicating resources to supporting the growth of local biotechnology industries. Why have they been investing billions of d Commentary Vol.15 No. 3 (2009) Can genetic engineering prevent food-poisoning? Henry Miller The largest outbreak of food-borne illness in a decade sickened over 1400 people in various parts of the United States in 2008. Originally thought to be caused by tomatoes Article Vol.15 No. 3 (2009) Bottom line compliance for biotechnology: Six secrets John Avellanet Biotechnology executives frequently short-shrift one of the key indicators of return on investment when negotiating pharmaceutical partnerships, support or licensing: a Article Vol.15 No. 3 (2009) Maturation of the biotechnology industry changes job opportunities for scientists Helen Liu The biotechnology industry has historically had a strong focus on innovation and research. As the industry has matured, companies have become intensely focused on comme Article Vol.15 No. 3 (2009) Biotechnology business models: An Indian perspective Viren Konde A typical business model consists of three components – value proposition, value-chain structure and revenue generation. These components are used to give a gene Article Vol.15 No. 3 (2009) Tracking progress: Two approaches to biotechnology development – Cases from Central Europe Tomasz Mroczkowski A number of emerging economies increasingly expend resources to improve national innovative capabilities and create knowledge economies through the development of biote Article Vol.15 No. 3 (2009) Umbilical cord blood banks: Modern day alchemy Helen Smith Stem cells are at the forefront of hopes for developing treatments for a range of serious diseases. The sources of those stem cells can be controversial, particularly f Article Vol.15 No. 3 (2009) China 10-Point Patent Checklist: Integrating patents into an overall business strategy for a Western manufacturing entity in China Catherine Sun The protection of intellectual property (IP) involved with manufactured goods comprises many aspects: Without even touching upon patents, these aspects include trade se From the Classroom Vol.15 No. 3 (2009) Bioscience enterprise: Postgraduate education at Cambridge and Auckland Linda Allan Leading universities around the world are addressing the demand for science-business-skilled professionals with a variety of novel programmes. The University of Cambrid Legal and Regulatory Updates Vol.15 No. 3 (2009) Legal and regulatory update John Wilkinson   Book Review Vol.15 No. 3 (2009) Book Review: Spin-outs: Creating businesses from university intellectual property Arlen D Meyers Spin-outs: Creating businesses from university intellectual propertyGraham Richards (ed.)Harriman House, Petersfield, UK, hardback, 184pp.,ISBN: 978-1905641987 Book Review Vol.15 No. 3 (2009) Book Review: Venture capital and the European biotechnology industry Leonard Lerer Venture capital and the European biotechnology industryWilliam BainsPalgrave Macmillan, Basingstoke, 2008, hardback, 232pp.,ISBN: 978-0230217195
